» Articles » PMID: 20487531

The Value of Ultrasonography in Predicting Arthritis in Auto-antibody Positive Arthralgia Patients: a Prospective Cohort Study

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2010 May 22
PMID 20487531
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Ultrasonography (US) has better sensitivity than clinical evaluation for the detection of synovitis in early rheumatoid arthritis (RA). Patients presenting with arthralgia and a positive anti-citrullinated protein antibodies (ACPA) and/or Rheumatoid Factor (IgM-RF) status are at risk for developing RA. In the present study, US utility and predictive properties in arthralgia patients at risk for the development of arthritis were studied.

Methods: 192 arthralgia patients with ACPA and/or IgM-RF were included. Absence of clinical arthritis was confirmed by two physicians. US was performed by one of two trained radiologists of any painful joint, and of adjacent and contralateral joints. Joint effusion, synovitis and power Doppler (PD) signal in the synovial membrane of the joints and tenosynovitis adjacent to the joint were evaluated and classified on a 4-grade semi-quantitative scale. Grade 2-3 joint effusion, synovitis, tenosynovitis and grade 1-3 Power Doppler signal were classified as abnormal.

Results: Forty-five patients (23%) developed arthritis after a mean of 11 months. Inter-observer reliability for synovitis and PD was moderate (kappa 0.46, and 0.56, respectively) and for joint effusion low (kappa 0.23). The prevalence of tenosynovitis was too low to calculate representative kappa values. At joint level, a significant association was found between US abnormalities and arthritis development in that joint for joint effusion, synovitis and PD. At patient level, a trend was seen towards more arthritis development in patients who had US abnormalities for joint effusion, synovitis, PD and tenosynovitis.

Conclusions: US abnormalities were associated with arthritis development at joint level, although this association did not reach statistical significance at patient level. US could potentially be used as a diagnostic tool for subclinical arthritis in seropositive arthralgia patients. However, further research is necessary to improve test characteristics.

Citing Articles

Predicting Rheumatoid Arthritis Development Using Hand Ultrasound and Machine Learning-A Two-Year Follow-Up Cohort Study.

Daskareh M, Vakilpour A, Barzegar-Golmoghani E, Esmaeilian S, Gilanchi S, Ezzati F Diagnostics (Basel). 2024; 14(11).

PMID: 38893708 PMC: 11171890. DOI: 10.3390/diagnostics14111181.


Food-derived bioactive peptides potentiating therapeutic intervention in rheumatoid arthritis.

Liu C, Yan Z, Zhang X, Xia T, Ashaolu J, Olatunji O Heliyon. 2024; 10(10):e31104.

PMID: 38778960 PMC: 11109807. DOI: 10.1016/j.heliyon.2024.e31104.


When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis.

Paroli M, Sirinian M Antibodies (Basel). 2023; 12(4).

PMID: 37987247 PMC: 10660552. DOI: 10.3390/antib12040069.


Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.

Di Matteo A, De Lorenzis E, Duquenne L, Nam J, Garcia-Montoya L, Harnden K Rheumatology (Oxford). 2023; 63(8):2213-2221.

PMID: 37934127 PMC: 11292136. DOI: 10.1093/rheumatology/kead570.


Joint involvement in RA starts predominantly in the hands: functional, clinical and imaging studies in clinically suspect arthralgia and during progression to RA.

Khidir S, van Dijk B, Krijbolder D, Verstappen M, van Mulligen E, van der Helm-van Mil A RMD Open. 2023; 9(2).

PMID: 37328293 PMC: 10277539. DOI: 10.1136/rmdopen-2023-003107.


References
1.
Naredo E, Rodriguez M, Campos C, Rodriguez-Heredia J, Medina J, Giner E . Validity, reproducibility, and responsiveness of a twelve-joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2008; 59(4):515-22. DOI: 10.1002/art.23529. View

2.
Rantapaa-Dahlqvist S, de Jong B, Berglin E, Hallmans G, Wadell G, Stenlund H . Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003; 48(10):2741-9. DOI: 10.1002/art.11223. View

3.
Ritchie D, Boyle J, McInnes J, Jasani M, Dalakos T, Grieveson P . Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968; 37(147):393-406. View

4.
Bos W, Wolbink G, Boers M, Tijhuis G, de Vries N, van der Horst-Bruinsma I . Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis. 2009; 69(3):490-4. DOI: 10.1136/ard.2008.105759. View

5.
Scheel A, Hermann K, Kahler E, Pasewaldt D, Fritz J, Hamm B . A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2005; 52(3):733-43. DOI: 10.1002/art.20939. View